Loading...
002198 logo

Guangdong Jiaying Pharmaceutical Co., LtdSZSE:002198 Stock Report

Market Cap CN¥1.5b
Share Price
n/a
1Y-50.7%
7D-9.9%
1D-1.6%
Portfolio Value
View

Guangdong Jiaying Pharmaceutical Co., Ltd

SZSE:002198 Stock Report

Market Cap: CN¥1.5b

Guangdong Jiaying Pharmaceutical (002198) Stock Overview

Guangdong Jiaying Pharmaceutical Co., Ltd. More details

002198 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance1/6
Financial Health4/6
Dividends0/6

Risk Analysis


002198 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Guangdong Jiaying Pharmaceutical Co., Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Guangdong Jiaying Pharmaceutical
Historical stock prices
Current Share PriceCN¥3.00
52 Week HighCN¥8.43
52 Week LowCN¥2.93
Beta-0.065
1 Month Change-22.08%
3 Month Change-62.03%
1 Year Change-50.74%
3 Year Change-66.56%
5 Year Change-69.14%
Change since IPO-31.82%

Recent News & Updates

Recent updates

Analysis Article Nov 20

Revenues Not Telling The Story For Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) After Shares Rise 31%

Guangdong Jiaying Pharmaceutical Co., Ltd ( SZSE:002198 ) shareholders have had their patience rewarded with a 31...
Analysis Article Nov 06

Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Jiaying Pharmaceutical (SZSE:002198)

A lackluster earnings announcement from Guangdong Jiaying Pharmaceutical Co., Ltd ( SZSE:002198 ) last week didn't sink...
Analysis Article Jul 03

Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Guangdong Jiaying Pharmaceutical Co., Ltd ( SZSE:002198 ) shareholders would be excited to see that the share price has...
Analysis Article May 03

There May Be Reason For Hope In Guangdong Jiaying Pharmaceutical's (SZSE:002198) Disappointing Earnings

The market for Guangdong Jiaying Pharmaceutical Co., Ltd's ( SZSE:002198 ) shares didn't move much after it posted weak...
Analysis Article Mar 12

Earnings Not Telling The Story For Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198)

With a price-to-earnings (or "P/E") ratio of 73.7x Guangdong Jiaying Pharmaceutical Co., Ltd ( SZSE:002198 ) may be...

Shareholder Returns

002198CN PharmaceuticalsCN Market
7D-9.9%-1.3%-1.9%
1Y-50.7%-14.5%28.6%

Return vs Industry: 002198 underperformed the CN Pharmaceuticals industry which returned -14.5% over the past year.

Return vs Market: 002198 underperformed the CN Market which returned 28.6% over the past year.

Price Volatility

Is 002198's price volatile compared to industry and market?
002198 volatility
002198 Average Weekly Movement7.1%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.7%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 002198 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002198's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003594Yong Ping Yougdjyzy.com.cn

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Shufeng Huoluo tablets, Tiaomeng Huoxue tablets, etc. Guangdong Jiaying Pharmaceutical Co., Ltd.

Guangdong Jiaying Pharmaceutical Co., Ltd Fundamentals Summary

How do Guangdong Jiaying Pharmaceutical's earnings and revenue compare to its market cap?
002198 fundamental statistics
Market capCN¥1.49b
Earnings (TTM)CN¥27.53m
Revenue (TTM)CN¥385.04m
54.2x
P/E Ratio
3.9x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002198 income statement (TTM)
RevenueCN¥385.04m
Cost of RevenueCN¥183.77m
Gross ProfitCN¥201.26m
Other ExpensesCN¥173.73m
EarningsCN¥27.53m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.055
Gross Margin52.27%
Net Profit Margin7.15%
Debt/Equity Ratio2.7%

How did 002198 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/28 23:37
End of Day Share Price 2026/06/26 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guangdong Jiaying Pharmaceutical Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.